Related Experiment Video
Updated: May 10, 2026
09:11
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
Commentary on Editorial: Omitting Radiation for Breast Cancer Patients Eligible for the NSABP B51 Trial Who Achieve
1Department of Radiation Oncology, Rutgers Cancer Institute, New Brunswick, New Jersey.
Practical Radiation Oncology
|May 8, 2026
Abstract
No abstract available in PubMed .